GREEN JAMES E 4
4 · KING PHARMACEUTICALS INC · Filed Jan 21, 2009
Insider Transaction Report
Form 4
GREEN JAMES E
Exec Vice Pres Corp Affairs
Transactions
- Award
Common Stock
2009-01-16+1,189→ 82,639 total - Exercise/Conversion
Common Stock
2008-12-31+6,540→ 81,450 total - Exercise/Conversion
Long-Term Performance Unit
2008-12-31−6,540→ 0 totalExp: 2008-12-31→ Common Stock (6,540 underlying)
Footnotes (1)
- [F1]Each Long-Term Performance Unit represented a contingent right to receive a share of King Pharmaceuticals, Inc. common stock if the reporting person remained employed by King Pharmaceuticals, Inc. during the two-year vesting period that ended on December 31, 2008.